Tixocortol
Medication
- A07EA05 (WHO) R01AD07 (WHO)
- (11β)-11,17-Dihydroxy-21-mercaptopregn-4-ene-3,20-dione
- 61951-99-3
N
- 162955
- 143053
Y
- ZX3KEK657Z
- D08610 Y
- DTXSID30895062
- Interactive image
- O=C4\C=C2/[C@]([C@H]1[C@@H](O)C[C@@]3([C@@](O)(C(=O)CS)CC[C@H]3[C@@H]1CC2)C)(C)CC4
InChI
- InChI=1S/C21H30O4S/c1-19-7-5-13(22)9-12(19)3-4-14-15-6-8-21(25,17(24)11-26)20(15,2)10-16(23)18(14)19/h9,14-16,18,23,25-26H,3-8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1Y
- Key:YWDBSCORAARPPF-VWUMJDOOSA-NY
N
Y (what is this?) (verify)Tixocortol is a corticosteroid used as an intestinal anti-inflammatory[1] and decongestant.
See also
- Tixocortol pivalate
References
- ^ Larochelle P, Du Souich P, Bolte E, Lelorier J, Goyer R (March 1983). "Tixocortol pivalate, a corticosteroid with no systemic glucocorticoid effect after oral, intrarectal, and intranasal application". Clinical Pharmacology and Therapeutics. 33 (3): 343–50. doi:10.1038/clpt.1983.43. PMID 6402333. S2CID 29876079.
- v
- t
- e
| Natural | |
|---|---|
| Synthetic |
|
- Antagonists: Aglepristone
- Ketoconazole
- Mifepristone
- Ulipristal acetate
- #WHO-EM
- ‡Withdrawn from market
- Clinical trials:
- †Phase III
- §Never to phase III
- See also
- Glucocorticoid receptor modulators
- Mineralocorticoids and antimineralocorticoids
- List of corticosteroids
 | This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
 | This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
- v
- t
- e
